Interneuron Licenses Treatment For Liver Disease

, Inc. has exercised its option and entered into an agreement to license IP 501, an orally-administered anti-fibrotic purified phospholipid compound in Phase 3 development for the treatment and prevention of liver diseases, including alcohol and Hepatitis C-induced cirrhosis.

The license agreement gives Interneuron rights to develop and commercialise the drug in several major markets, including the United States and Japan.

In addition, the Company announced the initiation of a government-funded Phase 3 clinical trial evaluating IP 501 in Hepatitis C. IP 501 is the subject of a recently completed Phase 3 clinical trial funded by the government to evaluate the compound in alcoholic cirrhosis.

The primary endpoint of the study is reduction in the progression of cirrhosis among drug-treated pre-cirrhotic patients compared with placebo patients, as measured by serial liver biopsies.

The Company expects to receive a preliminary analysis of the data in the first quarter of this year.

In addition to this trial, IP 501 is also being studied in another government-funded, multi-centre, Phase 3 clinical trial.

This recently initiated, multi-year trial is designed to evaluate the safety and effectiveness of IP 501 in treating patients with Hepatitis C-associated cirrhosis.

Under the terms of the license agreement, the Company has acquired rights to develop and commercialise IP 501 in the United States, Canada, Japan, Korea, and, under certain circumstances, Europe and other markets.

Interneuron is responsible for all remaining clinical and regulatory development, manufacturing, and marketing of the compound.

Interneuron Pharmaceuticals is a biopharmaceutical company engaged in the development and commercialisation of a diversified portfolio of product candidates, including multiple compounds in late- stage clinical development.

Purchase Dragon Pharma Labs on the Internet

Clomid - Bulk Price

Administration: Oral
Basic Chemical Name: Clomiphene Citrate
Manufacturer: Dragon Pharma LLC
Package: 10 x 100 pastilles (50 mg/tablet)
Price: 10 x $63.00

Cut Long 300

Injectable Anabolic Steroid
Prime Chemical Name: Drostanolone Enanthate, Testosterone Enanthate, Trenbolone Enanthate
Produced by: Dragon Pharma LLC
Pack: 1 X 10 ml (300 mg/ml)

Clenbuterol - Cheap Price

Administration: Oral
Main Chemical Name: Clenbuterol Hydrochloride
Produced by: Dragon Pharma LLC
Package: 20 x 100 tablets (40 mcg/pill)
Price: 20 x $25

Deca 500

Injectable Anabolic Steroid
Basic Component: Nandrolone Decanoate
Produced by: Dragon Pharmaceuticals
Pack: 1 X 10 ml (500 mg/ml)

TriTren 150 - Discount Price

Administration: Injection
Base Substance: Tri Trenbolone
Produced by: Dragon Pharma Labs
Pack: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $55.00

Trenbolone 200

Injectable Anabolic Steroid
Basic Component: Trenbolone Enanthate
Producer: Dragon Pharmaceuticals
Unit: 1 X 10 ml (200 mg/ml)

Trenbolone 200 - Cheap Price

Administration: Injection
Active Chemical Name: Trenbolone Enanthate
Manufacturer: Dragon Pharmaceuticals
Amount: 20 x 10 mL vial (200 mg/mL)
Price: 20 x $67.00

Tritren 150

Injectable Anabolic Steroid
Prime Ingredient: Trenbolones Blend
Manufacturer: Dragon Pharma LLC
Amount: 1 X 10 ml (150 mg/ml)

EQ 300

Injectable Anabolic Steroid
Principal Chemical Name: Boldenone Undecylenate
Manufacturer: Dragon Pharma Labs
Package: 1 X 10 ml (300 mg/ml)

Winstrol 50

Injectable Steroid for Muscle Growth
Principal Chemical Name: Stanozolol
Made by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (50 mg/mL)

Trenbolone 200 [10 Vials]

Injectable Steroid for Muscle Growth
Primary Component: Trenbolone Enanthate
Branded by: Dragon Pharma
10 Vials [10 mL per Vial (200 mg/ml)]
Price: 10 x $77.00 = $770.00 in Total

Deca 300 [10 Vials]

Injectable Steroid for Muscle Growth
Prime Substance: Nandrolone Decanoate
Produced by: Dragon Pharmaceuticals
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $45.00 = $450.00 in Total